Retinoic acid enhances TRAIL-induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expression

Cancer Research

Volumn 71, Issue 15, 2011, Pages 5245-5254

  Dhandapani, Latha ^a   Yue, Ping ^a   Ramalingam, Suresh S ^a   Khuri, Fadlo R ^a   Sun, Shi Yong ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 4; RETINOIC ACID; RETINOIC ACID RECEPTOR; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DNA BASE COMPOSITION; DNA FLANKING REGION; DRUG POTENTIATION; DRUG SENSITIVITY; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TRAIL R1 GENE; TRANSCRIPTION REGULATION;

5' FLANKING REGION; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; RECEPTORS, RETINOIC ACID; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; RESPONSE ELEMENTS; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTIONAL ACTIVATION;

EID: 79960939159     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-4180     Document Type: Article

References (22)

1. Sun SY, Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 2002;41:41-55. (Pubitemid 34051581)
2. Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H. RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov 2007;6:793-810. (Pubitemid 47504871)
3. Noy N. Between death and survival: retinoic acid in regulation of apoptosis. Annu Rev Nutr 2010;30:201-17.
4. Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004;328:1-16. (Pubitemid 38352876)
5. Chambon P. A decade of molecular biology of retinoic acid receptors. Faseb J 1996;10:940-54. (Pubitemid 26285969)
6. Newsom-Davis T, Prieske S, Walczak H. Is TRAIL the holy grail of cancer therapy? Apoptosis 2009;14:607-23.
7. Falschlehner C, Ganten TM, Koschny R, Schaefer U, Walczak H. TRAIL and other TRAIL receptor agonists as novel cancer therapeutics. Adv Exp Med Biol 2009;647:195-206.
8. Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C. TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev Recent Clin Trials 2009;4:34-41.
9. Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med 2001;7:680-6. (Pubitemid 32588023)
10. Clarke N, Jimenez-Lara AM, Voltz E, Gronemeyer H. Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. Embo J 2004;23:3051-60. (Pubitemid 39093599)
11. Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, et al. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res 1997;57:4931-9. (Pubitemid 27469005)
12. Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, et al. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res 2000;6:1563-73. (Pubitemid 30226247)
13. Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 2004;96:1769-80. (Pubitemid 39654571)
14. Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, et al. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Cancer Res 2007;67:4981-8. (Pubitemid 46910207)
15. Guan B, Yue P, Lotan R, Sun SY. Evidence that the human death receptor 4 is regulated by activator protein 1. Oncogene 2002;21:3121-9. (Pubitemid 34548083)
16. Pfahl M, Tzukerman M, Zhang XK, Lehmann JM, Hermann T, Wills KN, et al. Nuclear retinoic acid receptors: cloning, analysis, and function. Methods Enzymol 1990;189:256-70.
17. Tanaka T, Suh KS, Lo AM, De Luca LM. p21WAF1/CIP1 is a common transcriptional target of retinoid receptors: pleiotropic regulatory mechanism through retinoic acid receptor (RAR)/retinoid X receptor (RXR) heterodimer and RXR/RXR homodimer. J Biol Chem 2007;282:29987-97. (Pubitemid 350035294)
18. Stromskaya TP, Rybalkina EY, Zabotina TN, Shishkin AA, Stavrovskaya AA. Influence of RARalpha gene on MDR1 expression and P-glycoprotein function in human leukemic cells. Cancer Cell Int 2005;5:15.
19. Sun SY. Chemopreventive agent-induced modulation of death receptors. Apoptosis 2005;10:1203-10.
20. Elrod HA, Sun SY. Modulation of death receptors by cancer therapeutic agents. Cancer Biol Ther 2007;7:163-73.
21. Sun SY. How much do we know about retinoid-regulated genes? Cancer Biol Ther 2002;1:28-30.
22. Ammirante M, Di Giacomo R, De Martino L, Rosati A, Festa M, Gentilella A, et al. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin. Cancer Res 2006;66:4385-93.